NPY-(13-36) (pig)
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC |
| InChIKey | BJKPGURDHQQYOX-QGTLAHJGSA-N |
| Sequence | PAEDLARYYSALRHYINLITRQRY |
Chemical properties
| Hydrogen bond acceptors | 40 |
| Hydrogen bond donors | 44 |
| Rotatable bonds | 95 |
| Molecular weight (Da) | 2981.6 |
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| Y2 | NPY2R | Human | Neuropeptide Y | A | pKi | 8.6 | 8.65 | 8.7 | Guide to Pharmacology |
| Y4 | NPY4R | Human | Neuropeptide Y | A | pKi | 6.9 | 6.9 | 6.9 | Guide to Pharmacology |
| Y5 | NPY5R | Human | Neuropeptide Y | A | pKi | 7.3 | 7.3 | 7.3 | Guide to Pharmacology |
| Y1 | NPY1R | Rat | Neuropeptide Y | A | pKi | 7.8 | 7.8 | 7.8 | Guide to Pharmacology |
| Y4 | NPY4R | Rat | Neuropeptide Y | A | pKi | 6.3 | 7.25 | 8.2 | Guide to Pharmacology |
| Y5 | NPY5R | Rat | Neuropeptide Y | A | pKi | 7.7 | 7.7 | 7.7 | Guide to Pharmacology |
| Y1 | NPY1R | Human | Neuropeptide Y | A | pKi | 6.34 | 6.34 | 6.34 | ChEMBL |
| Y2 | NPY2R | Human | Neuropeptide Y | A | pKi | 9.1 | 9.1 | 9.1 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| Y2 | Q9ERC0 | Rat | Neuropeptide Y | A | pIC50 | 7.82 | 7.82 | 7.82 | ChEMBL |